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During the last century low back pain has been emerged as a widespread disease 
often caused by intervertebral disc degeneration (IDD). IDD in turn is a complex 
problem, in which a variety of causes play a crucial role. As IDD causes high costs, a 
corporate interest leads to a number of therapies developed. Today, these therapies 
focus on the restoration of the IVD function and not only on minimizing the pain 
caused by this disease.  
These approaches are often biological and aim to stimulate the regeneration of the 
intervertebral disc by injection of activator proteins, biomaterials, different cell types 
or complex cell-matrix-composites. Furthermore, the genetic engineering of disc cells 
and the in vitro tissue engineering offer a possibility for curing IDD. This article gives 
an overview on the concepts mentioned above. 
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Low back pain (LBP) is one of the most common musculoskeletal disease [1, 2]; it is 
estimated that 84% of the population will experience LBP at some point in their 
lifetime [3, 4], reaching a maximum rate of incidence in the 45- to 64-year-old age 
group [5, 6]. In addition to direct costs for LBP treatment, indirect costs, such as loss 
of productivity, are enormous. The causes for LBP are complex and of different 
origin, but one main reason for LBP is the degeneration of the intervertebral disc. 
 
IVD BIOLOGY AND DEGENERATION 
The intervertebral disc (IVD) is a fibrocartilagineous structure, composed of a central 
nucleus pulposus (NP) surrounded circumferentially by the annulus fibrosus (AF) 
(Fig.1). Each component is populated with different cell types and differs in the 
composition of the extracellular matrix (ECM) produced by the cells. The NP cells are 
round and lays within a lacunae (chondrocyte-like) while the AF cells are more 
fibroblastic and elongated. The ECM produced by the NP cells is rich in 
proteoglycans (PGs), predominantly aggrecan and type-II collagen, whereas the AF 
cells produce a matrix which is rich in type-I collagen with little PG or type-II collagen 
[7]. Further on, the IVD is avascular so that nutrient supply is restricted to diffusion.  
The degeneration of IVD is multi-factorial and influenced by age and genetic loading 
[8], biomechanical [9, 10] and environmental factors such as immobilization, trauma, 
consumption of tobacco [11], diabetes, vascular and infectious diseases [12]. Healthy 
discs are characterized by a balance between anabolic and catabolic processes 
which are regulated by anabolic growth factors (e.g. IGF1 [insulin-like growth factor 
1], TGFβs [transforming growth factors β], BMPs [bone morphogenetic proteins]) [13] 
and to some extent by notochordal cells [14] or rather by catabolic enzymes like 
MMPs (matrix metalloproteases) [15, 16] and ADAMTS (a disintegrin and 
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metalloprotease with thrombospondin motifs) [17] as well as proinflammatory 
cytokines (e.g. IL-1 [interleukine-1], TNF-α [tumor necrosis factor α]) [18]. In the 
course of IVD degeneration (IDD), changes in IVD morphology [19] and matrix 
composition i.e. the loss of proteoglycanes and type-II collagen [20] as well as an 
increase of cell death [21] and a decrease of nutrient diffusion [22] are observed. 
This is often caused by a metabolic imbalance that means an up-regulation of 
inflammatory mediators and MMPs [23], the accumulation of regulatory matrix 
degradation products (e.g. fibronectin fragments) [24, 25] and reactive oxygen 
species [26] which seem to be responsible for the inhibition of matrix synthesis and 
repair.  
 
CELLBASED THERAPY OF DEGENERATED IVD  
Traditional treatment to manage IDD and discogenic pain include surgical 
intervention with total disc excision or minimal invasive procedures [7]. These 
treatments can reduce the pain, but are not capable of regenerating the discs. 
Therefore, lots of outcomes including several biological approaches have been 
focused on restoring the IVD structure and function (Fig. 2).  
 
Release of Growth Factors 
The synthesis of matrix components and the proliferation of the IVD cells are 
influenced by several growth factors and enzymes [13]. Thus the direct injection of 
activators such as pure protein solution or as a combination with a slow-release 
matrix is an easy way to stimulate IVD regeneration. Members of the TGFβ 
superfamily are potent stimulators of IVD restoration. The addition of recombinant 
TGFβ and epidermal growth factor has been demonstrated to increase the 
5 
 
proteoglycan synthesis of canine cells severalfold [27, 28]. Promising results have 
been shown by the injection of BMP7. After an injection of BMP7 into the discs of 
rabbits, IVD proteoglycan synthesis increased and the disc height was restored, 
whereby this effect was stable over eight weeks [29]. Similar results were observed in 
a rat model [30]. Treatment of disc cells with GDF5 (growth differentiation factor 5) 
has been shown to stimulate the extracellular matrix synthesis in vitro and restore the 
disc structure in a rabbit disc-injury model in vivo [31].  
Often, the assignability of results from an animal model to patients is problematic. In 
this case, a pilot study led to similar conclusions for humans. After patient treatment 
with a mixture of matrix components and growth factors via direct injection, an 
induction of IVD regeneration over 13 months was seen [32]. This indicates that 
direct injection of active substances could offer a possibility for IVD regeneration. 
Nevertheless, the effort of this technique is limited by the presence of viable cells and 
likely to be suitable for early or moderate stage of IDD. Furthermore, this form of 
stimulation is only short-term. 
 
Gene Therapy 
For a long-term stimulation, it would be more effective to integrate the activator 
directly into the genome of disc cells (gene therapy). The genetic change can occur 
in vivo (i.e. direct transfection) or ex vivo (i.e. removal of the cells, transfection in vitro 
and return of transfected cells into IVD) [33], but due to safety reasons, the ex vivo 
gene therapy is mostly privileged. The gene of the activator has to be transported into 
the cell by a vehicle which can be a virus or a nonviral carrier. The nonviral gene 
transfer is more inefficient [34], that’s why viral gene transfer is preferred. 
Unfortunately the used adenoviruses often cause strong immune reactions in vivo 
[35, 36]. To minimize these reactions, adeno-associated viral vector are used, which 
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has already shown positive results for IVD regeneration in vivo [37]. Adeno-mediated 
therapy of human disc cells with transcription factors (e.g. Sox9 [(sex determining 
region Y)-box 9]), growth factors (e.g. TGFβ, BMP2) and anabolic enzymes (e.g. 
LMP1 [latent membrane protein 1], TIMP [tissue inhibitor of metalloproteinases]) led 
to some restoration of IVD structure and increased synthesis of proteoglycanes and 
collagen [33, 38, 39]. Moreover, the combination of growth factors showed synergistic 
effects on the expression of different IVD markers in human disc cells in vitro [40]. 
Despite promising results, this approach has some limitations. First, up to now little is 
known about the influence on regulatory pathways caused by unlimited and 
uncontrolled release of growth factors. Second, for a successful gene transfer healthy 
autologous disc cells are needed but these are limited in degenerated IVDs. That 
means it is questionable, if degenerated discs contain enough viable cells and if after 
transfection these cells are potent enough to express a sufficient amount of growth 
factor in the degraded IVD of the patient. 
 
Tissue Engineering 
For intense degeneration of IVD (grade V) with loss of cell proliferation and disc 
structure a complete replacement of the IVD will be necessary. Therefore, tissue 
engineering, that means the cultivation of disc cells on a 3D scaffold, could be a 
possible approach. Up to now, it is not possible to create a functional IVD in vitro, but 
the development of several biomaterials imitating properties of IVD and an increasing 
understanding of disc cell biology mean that tissue engineering of the IVD may soon 
become reality [41]. There are lots of investigations concerning in vitro cultivation of 
disc cells on a 3D scaffold ongoing. Similar to the natural conditions several forms of 
stimulation, like the application of pressure [42-44] and/or other physical forces [45] 
are used during cultivation. A variety of studies have been described improving the 
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tissue engineering of AF cells [46-49], NP cells [50, 51] or both cell types [52]. 
Despite some optimistic results, this technique is still far from clinical use. One major 
hurdle of current in vitro engineered disc replacement is an insufficient biomechanical 
behavior, which is not comparable with natural IVDs. Furthermore, the insertion of the 
engineered tissue generates spacious injuries and the integration of the new tissue 
into the existent IVD is often inadequate.  
 
Cell Transplantation 
Minimally invasive methods of IDD treatment are focused, because of the limitations 
of in vitro tissue engineering mentioned above. Often these minimally invasive 
methods use the patient body as a kind of bioreactor for the cultivation of cells. Such 
a minimal invasive technique to regenerate IDD is the injection of viable cells. It has 
been shown, that the supplementation with autologous mesenchymal stem cells 
(MSC) [53-56], NP cells [57, 58] or chondrocytes [59, 60] demonstrates regenerative 
effects concerning IDD in rabbit models. Moreover, in a clinical pilot study for disc 
repair with autologous chondrocytes, patients showed stimulated matrix regeneration 
and a relief of pain after cell transplantation [61]. Although autologous cells have the 
advantage of causing no immune response, the extraction of appropriate cells in 
sufficient amounts is difficult. For instance, the density of NP cells in IVD is low and 
these cells as well as chondrocytes cannot be expanded in monolayer cultures 
because they lose their phenotype characteristics [62, 63]. Furthermore, additional 
surgery is needed and potential genetic dispositions are still possible. 
The avascular structure of the IVD determines its immune privilege. Even the 
injection of allogeneic NP cells causes no infiltration of lymphocytes [64]. That is why 
allogeneic cells in particular MSCs are an attractive source for IVD degeneration. 
Adult MSC are pluripotent stem cells that have been found in almost every organ in 
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adulthood [65]. These cells are of high plasticity and have the capacity of 
multilineage differentiation [66]. In addition, they are accessible in sufficient quantities 
from bone marrow [67] and fat tissue [68] and comparably easy to expand and 
manipulate [69] which make them ideal candidates for cell-based IVD regeneration 
[70]. Furthermore allogeneic MSCs are off-the-shelf available, which means the time 
span for cell isolation and expansion is omitted. Moreover, the use of allogeneic 
MSCs eliminates potential genetic dispositions and limited potency dependent on the 
age of the patient. 
Indeed, the injection of pure cell solution led to extensive leakage of these cells 
through the injection site [71]. It is thought that this leakage is caused by inner disc 
pressure. Despite promising results in animal models in vitro and in vivo and a pilot 
study with hematopoietic stem cells [72], an injection of MSC into the disc of humans 
has never been done. Currently it is still unclear to what extent such a therapy is 
efficient enough to reduce discogenic pain of LBP patients. 
 
Matrix-assisted Cell Transfer 
Compared to pure cell injection, it is possible to inject biomaterials which are ideal to 
restore the disc volume. Requirements for suitable materials are mechanical stability, 
biocompatibility and biodegradation, sterilizability and a low viscosity for injection 
devices. In general, biomaterials are injected as fluids which polymerize in the disc by 
crosslinking or addition of e.g. agarose [73]. Thereby, it is important that the 
polymerization is slow enough for injection and fast enough to prevent leakage of the 
material. To date analyzed biomaterials for IVD regeneration in certain animal models 
are silicones [74], chitosane [75], aldehyde-linked BSA [76] or components of ECM 
like hyaluron, fibrin [77], collagen [78] or silk-elastin-copolymers [79, 80]. The sole 
injection of biomaterials can only restore the disc volume but hardly its function. 
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Under circumstances functionality can be restored by injection of ECM components. 
It is known that several ECM components interact with the disc cells and influence 
their behavior [81]. Unfortunately, in the advanced stage of IDD often no viable cells 
are left to be stimulated.  
Consequently, a better effect could be reached, if biomaterials are used for matrix-
assisted cell transfer, injected as a mixture of cells and matrix. In this case, the gel-
like matrix prevents the leakage of the cells as shown in a study applying a mixture of 
fibrin/thrombin and HeLa-cells [71]. Furthermore, the matrix itself could stimulate 
ECM synthesis and cell proliferation. It is known that a close regulation is available 
between disc cells and their surrounding matrix [82]. To date, it is not known to what 
extent the ECM is capable to stimulate cell differentiation as well.  
 
SUMMARY AND FUTURE PROSPECTS 
The intervertebral disc has been shown to be a very unique, highly specialized tissue 
that undergoes massive alteration during degradation. To fulfill its natural function, 
the IVD needs a mechanically stable structure with a defined ECM to confer flexibility, 
as well. IDD caused by diverse circumstances creating a hostile environment, 
resulting in cell death and concomitant to a variation in matrix composition and finally 
to an extensive matrix decay. IDD is a global problem connected with enormous 
health restrictions and high costs.  
Therefore, a variety of therapeutically approaches has been developed trying to cure 
IDD patients. Despite lots of research in this area, an ideal treatment is not available 
yet. The most promising approach for IVD regeneration seems to be the matrix-
assisted cell transfer. Due to of diverse advantages, MSC are thought to be the 
appropriate cell source for that technique. During the last years, the importance of 
signaling between matrix and cells has been noticed [83]. Up to now, it is not known 
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how intense matrix components influence the differentiation or behavior of MSC. 
Because cells react on alterations in matrices via several surface receptors, it is 
possible that certain matrix components can induce differentiation of MSC. Although 
the presumption exists that MSCs can differentiate into disc cells, this has never 
been demonstrated. One impediment to confirm differentiation into a disc cell is our 
inability to identify these cells; there are no robust molecular, biochemical or biologic 
markers known. Up to now, disc cells are treated as chondrocytes although they 
clearly differ from this cell type [84]. That means that the markers for disc cells are 
the same as for chondrocytes. These markers like proteoglycanes, type II collagen 
etc. will so far be determined offline via staining or RT-PCR, which points another 
hurdle of cell-based therapy. There is a need in improvement of real-time observation 
techniques of cell proliferation and differentiation status as well as matrix production 
during cultivation in vitro or after application in vivo. 
The use of MSC as a cell source led to some open questions, too. It is not known 
which state of differentiation is needed for cell survival because undifferentiated MSC 
are not capable to survive in the rough IVD environment [85]. In addition, only 
differentiated or partly differentiated MSC can produce ECM, which is required for 
IVD regeneration. Due to the regulation and interaction of matrix and cells is quite 
complex, our knowledge is not sufficient to estimate all requirements to realize IVD 
regeneration.  
A complete IVD regeneration also needs the restoration of nutrient supply which is 
supported by the intervertebral endplates [73]. The solution of this problem is as 
complex as the regeneration of the basic disc structure and function. Finally many 
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Intervertebral disc with distinct regions. The outer region (1) is the annulus fibrosus 
and the inner region (2) the gelatinous nucleus pulposus. The picture was kindly 
provided by Prof. Dr. Stephanie Gokorsch.  
 
2  
Strategies for biological disc repair at different stages of intervertebral disc 
degeneration (IDD). The classification of IDD via morphological changes (grade) is 
based on the work of Thompson et al. [86]. The classification of IDD via CMS 
(composite MRI score) was done by Benneker et al. [87]. 
 
 
 
 
